SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950135-09-003209
Filing Date
2009-04-28
Accepted
2009-04-28 17:28:48
Documents
8
Period of Report
2009-06-02
Effectiveness Date
2009-04-28

Document Format Files

Seq Description Document Type Size
1 IDENIX PHARMACEUTICALS, INC. b74545dfdef14a.htm DEF 14A 573122
2 GRAPHIC b74545dfb7454500.gif GRAPHIC 2971
3 GRAPHIC b74545dfb7454509.gif GRAPHIC 2850
4 GRAPHIC b74545dfb7454502.gif GRAPHIC 1428
5 GRAPHIC b74545dfb7454504.gif GRAPHIC 1367
6 GRAPHIC b74545dfb7454505.gif GRAPHIC 8482
7 GRAPHIC b74545dfb7454503.gif GRAPHIC 6410
8 GRAPHIC b74545dfb7454506.gif GRAPHIC 10629
  Complete submission text file 0000950135-09-003209.txt   622732
Mailing Address 60 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address 60 HAMPSHIRE STREET . CAMBRIDGE MA 02139 (617) 995-9800
IDENIX PHARMACEUTICALS INC (Filer) CIK: 0001093649 (see all company filings)

IRS No.: 450478605
Type: DEF 14A | Act: 34 | File No.: 000-49839 | Film No.: 09776737
SIC: 2834 Pharmaceutical Preparations